Lake Street Maintains Buy on MDxHealth, Lowers Price Target to $3

Benzinga Newsdesk www.benzinga.com Negative 63.3%

Neg 63.3% Neu 0% Pos 0%

Lake Street analyst Thomas Flaten maintains MDxHealth (NASDAQ:MDXH) with a Buy and lowers the price target from $5 to $3.